Search results
Stocks in news: HDFC Bank, IDFC First Bank, IDBI Bank, Dr Reddy's, Lloyds Metals
The Economic Times· 2 days agoHDFC Bank advances rose 53% to Rs 24.87 lakh crore. LIC boosted IDFC First Bank's stake to 2.68%. Dr...
How to trade HDFC Bank stock after its fall today?
CNBC Awaaz· 1 day agoAs long as the stock is holding above its 50-day moving average, the bias remains positive. On the higher side, immediate resistance is at Rs 1,700.
Mid-Day Mood | Bank, realty stocks keep Nifty, Sensex in the red
CNBC Awaaz· 1 day agoBenchmark indices Nifty and Sensex failed to recover from today's open and continued to trade in the...
Investors lap up shares of Emcure, Bansal Wire; bids cross Rs 1.25 trillion
Business Standard India· 24 hours agoThe demand for both issuances reflects the positive sentiment among investors and could be a...
Sensex crosses 80,000 for first time, banking stocks lead rally
Tribune India· 4 days agoSensex and Nifty made a new all-time high of 80,039 and 24,292 respectively. On the National Stock...
Latest Market News Today Live Updates July 5, 2024: Gold Prices Today: Yellow metal hits one-month...
Livemint· 21 hours agoLatest Market News Today Live Updates: Follow Mint's market blog for real-time updates on your...
Here's why CA Rudramurthy BV is bullish on IRCTC
The Economic Times· 1 day ago"In fact, today dip whatever you got in market early morning because of HDFC Bank business update and because of which markets fell, that was again an...
Multibagger stock: Lupin shares rally after Kotak's double upgrade on pharma player
Business Today· 2 days agoShares of multibagger pharma stock Lupin Ltd surged during the trading session on Thursday after the...
The heartwarming reason behind Sushmita Sen’s birth date change - Times of India
The Times of India· 5 days agoFor beloved Bollywood icon Sushmita Sen, this moment came in the form of a life-threatening health...
Emcure Pharma IPO Day 2: Issue subscribed 2x; NIIs lead from the front
CNBC Awaaz· 2 days agoBrokerages have positively viewed Emcure Pharma's IPO, considering the public offer fairly priced...